FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

21681000087101: Menveo powder and solution for injection GlaxoSmithKline Inc. (real clinical drug)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Oct 2016. Module: Canada Health Infoway English module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
137481000087116 Menveo powder and solution for injection GlaxoSmithKline Inc. (real clinical drug) en Fully specified name Active Entire term case sensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)
71321000087114 Men-C-ACYW-135 Menveo GSK en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)
71341000087117 Menveo powder and solution for injection GlaxoSmithKline Inc. en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)
75941000087119 Men-C-ACYW-135 Menveo GSK fr Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Canada Health Infoway French module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Menveo powder and solution for injection GlaxoSmithKline Inc. (real clinical drug) a pour principe actif (attribut) Neisseria meningitidis serogroup A capsular oligosaccharide antigen conjugated to Corynebacterium diphtheriae CRM197 protein true Inferred relationship Some 1
Menveo powder and solution for injection GlaxoSmithKline Inc. (real clinical drug) est un(e) (attribut) Vaccine product containing only Neisseria meningitidis serogroup A, C, W135 and Y capsular oligosaccharide conjugated antigens (medicinal product) true Inferred relationship Some
Menveo powder and solution for injection GlaxoSmithKline Inc. (real clinical drug) a pour principe actif (attribut) Neisseria meningitidis serogroup C capsular oligosaccharide antigen conjugated to Corynebacterium diphtheriae CRM197 protein true Inferred relationship Some 2
Menveo powder and solution for injection GlaxoSmithKline Inc. (real clinical drug) Plays role Active immunity stimulant role (role) true Inferred relationship Some
Menveo powder and solution for injection GlaxoSmithKline Inc. (real clinical drug) Has supplier GlaxoSmithKline Inc. (supplier) true Inferred relationship Some
Menveo powder and solution for injection GlaxoSmithKline Inc. (real clinical drug) a pour principe actif (attribut) Neisseria meningitidis serogroup W135 capsular oligosaccharide antigen conjugated to Corynebacterium diphtheriae CRM197 protein true Inferred relationship Some 3
Menveo powder and solution for injection GlaxoSmithKline Inc. (real clinical drug) est un(e) (attribut) Product manufactured as parenteral dose form (product) true Inferred relationship Some
Menveo powder and solution for injection GlaxoSmithKline Inc. (real clinical drug) a une forme pharmaceutique (attribut) forme pharmaceutique pour usage parentéral (forme pharmaceutique) true Inferred relationship Some
Menveo powder and solution for injection GlaxoSmithKline Inc. (real clinical drug) Count of active ingredient quatre false Inferred relationship Some
Menveo powder and solution for injection GlaxoSmithKline Inc. (real clinical drug) Count of base of active ingredient un false Inferred relationship Some
Menveo powder and solution for injection GlaxoSmithKline Inc. (real clinical drug) a pour principe actif (attribut) Neisseria meningitidis serogroup Y capsular oligosaccharide antigen conjugated to Corynebacterium diphtheriae CRM197 protein true Inferred relationship Some 4
Menveo powder and solution for injection GlaxoSmithKline Inc. (real clinical drug) a pour principe actif (attribut) Meningococcus vaccine (substance) false Inferred relationship Some 1
Menveo powder and solution for injection GlaxoSmithKline Inc. (real clinical drug) est un(e) (attribut) Vaccine product containing only meningococcal groups A + C + Y + W-135 conjugate antigens (medicinal product) false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Administered tradename codes for vaccines reference set (foundation metadata concept)

Back to Start